US Patent No: 8,142,811

Number of patents in Portfolio can not be more than 2000

Controlled release hydrocodone formulations

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT353

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, US 47 1640
Masselink, John K Old Tappan, US 19 429
Oshlack, Benjamin New York, US 196 8658
Tonelli, Alfred P Congers, US 15 512

Cited Art Landscape

Patent Info (Count) # Cites Year
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4,708,874 Devices for the controlled release of active substances, as well as process for the preparation thereof 72 1986
 
PHARMACIA & UPJOHN (1)
5,614,218 Controlled release preparation 53 1994
 
ELAN CORPORATION, PLC (2)
4,609,542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 46 1985
5,637,320 Controlled absorption naproxen formulation for once-daily administration 58 1994
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 77 1990
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5,321,012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 161 1993
5,502,058 Method for the treatment of pain 141 1994
 
PFIZER INC. (1)
4,861,596 Rolled matrix device having enhanced ability to unroll and method for its production 24 1988
 
Takeda Pharmaceutical Company Limited (1)
5,026,560 Spherical granules having core and their production 155 1988
 
NIPPON SHINYAKU CO., LTD. (1)
5,456,923 Method of manufacturing solid dispersion 146 1993
 
Hoechst Aktiengesellschaft (1)
4,935,246 Process for the coating of granules 121 1988
 
CIBA-GEIGY CORPORATION (1)
4,548,990 Crosslinked, porous polymers for controlled drug delivery 126 1983
 
GRUENENTHAL GMBH (1)
5,601,842 Sustained release drug formulation containing a tramadol salt 73 1996
 
MERCK SHARP & DOHME CORP. (1)
4,377,568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 72 1981
 
RHODIA INC. (2)
6,264,983 Directly compressible, ultra fine acetaminophen compositions and process for producing same 27 1999
6,607,750 Directly compressible acetaminophen compositions 30 2001
 
WARNER-LAMBERT COMPANY (4)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 84 1983
4,600,645 Process for treating dosage forms 72 1985
5,068,110 Stabilization of enteric coated dosage form 74 1989
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 87 1992
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 285 1982
 
FISONS CORPORATION (1)
4,959,219 Coating barriers comprising ethyl cellulose 41 1988
 
ROEHM GMBH (1)
4,520,172 Method for coating medicaments 56 1983
 
American Cyanamid Company (1)
5,283,065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 101 1992
 
MERIAL (1)
5,958,425 Viral vaccines 3 1997
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 130 1989
 
ZYMA SA (1)
4,728,513 Granular delayed-release form of pharmaceutically active substances 77 1986
 
Duphar International Research B.V. (1)
5,219,575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 36 1990
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4,983,730 Water soluble cellulose acetate composition having improved processability and tensile properties 76 1988
 
Richardson-Vicks Inc. (1)
4,996,047 Sustained release drug-resin complexes 103 1988
 
ALZA CORPORATION (7)
5,019,397 Aqueous emulsion for pharmaceutical dosage form 93 1988
5,024,842 Annealed coats 87 1990
5,460,826 Morphine therapy 124 1994
6,491,945 Hydrocodone therapy 42 1994
5,593,695 Morphine therapy 61 1995
* 5,866,161 Hydrocodone therapy 48 1996
5,667,805 Morphine therapy 52 1996
 
VALEANT INTERNATIONAL BERMUDA (1)
5,518,730 Biodegradable controlled release flash flow melt-spun delivery system 206 1992
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 74 1982
 
EURO-CELTIQUE S.A. (12)
4,443,428 Extended action controlled release compositions 122 1982
4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 144 1986
5,071,646 Pharmaceutical ion exchange resin composition 136 1989
5,356,467 Controlled release coatings derived from aqueous dispersions of zein 188 1993
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 177 1993
5,670,172 Pharmaceutical spheroid formulation 92 1995
5,849,240 Method of preparing sustained release pharmaceutical compositions 148 1996
5,891,471 Pharmaceutical multiparticulates 132 1996
5,843,480 Controlled release diamorphine formulation 106 1996
5,879,705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 139 1997
5,965,163 Substained release compositions and a method of preparing pharmaceutical compositions 141 1997
6,572,885 Orally administrable opioid formulations having extended duration of effect 71 2001
 
Purdue Pharma L.P. (25)
4,828,836 Controlled release pharmaceutical composition 208 1987
4,834,985 Controlled release pharmaceutical composition 220 1987
4,990,341 Controlled release hydromorphone composition 158 1989
5,266,331 Controlled release oxycodone compositions 204 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 228 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 225 1992
5,549,912 Controlled release oxycodone compositions 198 1993
5,472,712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 209 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 190 1993
5,478,577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 205 1993
5,411,745 Powder-layered morphine sulfate formulations 135 1994
5,965,161 Extruded multi-particulates 161 1994
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 460 1995
5,508,042 Controlled release oxycodone compositions 214 1995
5,968,551 Orally administrable opioid formulations having extended duration of effect 214 1995
5,958,459 Opioid formulations having extended controlled released 137 1995
5,656,295 Controlled release oxycodone compositions 183 1996
5,681,585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 126 1996
5,672,360 Method of treating pain by administering 24 hour oral opioid formulations 204 1996
6,143,322 Method of treating humans with opioid formulations having extended controlled release 148 1997
5,958,452 Extruded orally administrable opioid formulations 191 1997
6,103,261 Opioid formulations having extended controlled release 140 1999
6,294,195 Orally administrable opioid formulations having extended duration of effect 138 1999
6,733,783 Controlled release hydrocodone formulations 122 2001
2004/0266,807 Controlled release hydrocodone formulations 45 2004
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5,384,130 Spherical seed cores, spherical granules and process for production thereof 58 1993
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 151 1987
 
Alpharma Pharmaceuticals, LLC (3)
5,202,128 Sustained release pharmaceutical composition 169 1990
5,330,766 Sustained release pharmaceutical composition 131 1993
5,378,474 Sustained release pharmaceutical composition 135 1993
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
4,464,378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 192 1981
 
Archimedes Development Limited (1)
5,629,011 Composition for nasal administration 88 1994
 
MILES INC. (1)
4,797,410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 46 1987
 
DRUGTECH CORPORATION (2)
5,122,384 Oral once-per-day organic nitrate formulation which does not induce tolerance 47 1989
5,133,974 Extended release pharmaceutical formulations 287 1990
 
FMC CORPORATION (3)
5,206,030 Film-forming composition and use for coating pharmaceuticals, foods and the like 60 1990
5,248,516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 48 1991
5,258,436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 38 1991
 
DepoMed Systems, Inc. (1)
5,007,790 Sustained-release oral drug dosage form 172 1989
 
UCB PHARMA, S.A. (1)
6,699,502 Pharmaceutical compositions for controlled release of active substances 41 1999
 
Glatt GmbH (1)
5,132,142 Apparatus and method for producing pellets by layering power onto particles 64 1991
 
GACELL LABORATORIES AB (3)
4,557,925 Membrane-coated sustained-release tablets and method 114 1984
5,178,868 Dosage form 69 1991
5,520,931 Controlled release morphine preparation 57 1995
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 86 1988
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 195 1986
4,970,075 Controlled release bases for pharmaceuticals 163 1989
 
WATSON LABORATORIES, INC. (1)
4,806,337 Erodible matrix for sustained release bioactive composition 136 1986
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 71 1991
 
FH FAULDING & CO LIMITED (1)
5,196,203 Theophylline dosage form 56 1991
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 144 1987
 
SHIONOGI & CO., LTD. (1)
5,023,089 Sustained-release preparations and the process thereof 63 1989
 
TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 121 1990
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
Purdue Pharma L.P. (15)
8,980,291 Controlled release hydrocodone formulations 3 2010
* 8,551,520 Controlled release hydrocodone 17 2012
8,975,271 Controlled release hydrocodone formulations 0 2013
* 9,060,940 Controlled release hydrocodone 2 2014
8,975,273 Controlled release hydrocodone formulations 1 2014
8,951,555 Controlled release hydrocodone formulations 5 2014
9,023,401 Controlled release hydrocodone formulations 6 2014
9,056,052 Controlled release hydrocodone formulations 5 2015
9,056,107 Controlled release hydrocodone formulations 0 2015
9,320,717 Controlled release hydrocodone formulations 0 2015
9,278,074 Controlled release hydrocodone formulations 0 2015
9,289,391 Controlled release hydrocodone formulations 0 2015
9,205,055 Controlled release hydrocodone formulations 0 2015
9,205,056 Controlled release hydrocodone formulations 0 2015
9,198,863 Controlled release hydrocodone formulations 0 2015
 
Egalet Ltd. (5)
8,877,241 Morphine controlled release system 1 2004
9,005,660 Immediate release composition resistant to abuse by intake of alcohol 0 2010
9,023,394 Formulations and methods for the controlled release of active drug substances 0 2013
8,808,745 Morphine polymer release system 3 2013
9,044,402 Abuse-deterrent pharmaceutical compositions for controlled release 0 2014
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 27, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 27, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00